EMERAMED Ltd — Form D/A
EMERAMED Ltd of DUBLIN, L2, a company, filed a Form D amendment with the SEC on 2016-06-17. $3.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-06-17
- Form: D/A
- Accession: 0001623416-16-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $3.6M
- Minimum investment: $1K
- Investors: 57
- Date of first sale: 2014-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-258240
Issuer
- Name: EMERAMED Ltd
- CIK: 0001623416
- Entity type: Corporation
- Jurisdiction: IRELAND
- Incorporated: 2014
- Address: TRINITY HOUSE, DUBLIN, L2, 6
- Phone: (859) 266-9200
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| BOYD E HALEY | Director | LEXINGTON, KY |
| BOYD E HALEY | Executive Officer | LEXINGTON, KY |
| BOYD E HALEY | Promoter | LEXINGTON, KY |
| DAVID C KENNEDY | Director | LEXINGTON, KY |
| RAGNAR E KLINGBERG | Director | LEXINGTON, KY |
| RAGNAR E KLINGBERG | Executive Officer | LEXINGTON, KY |
| KATHRYN M WACHSMAN | Director | LEXINGTON, KY |
| J Todd Renner | Director | Lexington, KY |
| J Todd Renner | Executive Officer | Lexington, KY |
| Ragnar M Klingberg | Director | Stockholm, V7 |
| Ragnar M Klingberg | Executive Officer | Stockholm, V7 |
| J. Todd Renner | Director | Lexington, KY |
| J. Todd Renner | Executive Officer | Lexington, KY |
| Christian M Krog-Jensen | Director | Segeltorp, V7 |
Other filings by this issuer (5)
More